Cargando…
Impact of mesenchymal stem cells’ secretome on glioblastoma pathophysiology
BACKGROUND: Glioblastoma (GBM) is a highly aggressive primary brain cancer, for which curative therapies are not available. An emerging therapeutic approach suggested to have potential to target malignant gliomas has been based on the use of multipotent mesenchymal stem cells (MSCs), either unmodifi...
Autores principales: | Vieira de Castro, Joana, Gomes, Eduardo D., Granja, Sara, Anjo, Sandra I., Baltazar, Fátima, Manadas, Bruno, Salgado, António J., Costa, Bruno M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625623/ https://www.ncbi.nlm.nih.gov/pubmed/28969635 http://dx.doi.org/10.1186/s12967-017-1303-8 |
Ejemplares similares
-
Do hypoxia/normoxia culturing conditions change the neuroregulatory profile of Wharton Jelly mesenchymal stem cell secretome?
por: Teixeira, Fábio G., et al.
Publicado: (2015) -
Crosstalk between glial and glioblastoma cells triggers the “go-or-grow” phenotype of tumor cells
por: Oliveira, Ana Isabel, et al.
Publicado: (2017) -
Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model
por: Mendes-Pinheiro, Bárbara, et al.
Publicado: (2019) -
Bursaphelenchus xylophilus and B. mucronatus secretomes: a comparative proteomic analysis
por: Cardoso, Joana M. S., et al.
Publicado: (2016) -
Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease
por: Teixeira, Fábio G., et al.
Publicado: (2016)